Answers are grounded in this paper and cite their sources.
Corrigendum corrects errors in abstract and results for efficacy and safety of dalbavancin in infective endocarditis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Suárez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: